Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.

Prenalterol, a beta1 agonist, was given in a single blind acute intravenous study to seven patients with cardiac failure (New York Heart Association class II and III). It was then given in a double blind crossover study of sustained oral prenalterol to six of them. As a result of dose titration stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Currie, P J, Kelly, M J, Middlebrook, K, Federman, J, Sainsbury, E, Ashley, J, Pitt, A
Médium: Artigo
Jazyk:Inglês
Vydáno: 1984
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC481544/
https://ncbi.nlm.nih.gov/pubmed/6326784
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky